Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients-Reference-Cited by-同舟云学术

Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients

Published:2022-07 Issue:7 Volume:22 Page:1873-1883
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Benning Louise^ORCID,Morath Christian^ORCID,Bartenschlager Marie,Kim Heeyoung,Reineke Marvin,Beimler Jörg,Buylaert Mirabel,Nusshag Christian^ORCID,Kälble Florian,Reichel Paula,Töllner Maximilian,Schaier Matthias^ORCID,Klein Katrin,Benes Vladimir,Rausch Tobias,Rieger Susanne,Stich Maximilian,Tönshoff Burkhard^ORCID,Weidner Niklas,Schnitzler Paul,Zeier Martin,Süsal Caner,Hien Tran Thuong,Bartenschlager Ralf,Speer Claudius^ORCID

Funder

Dietmar Hopp Stiftung

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.17054

Reference65 articles.

1. Adaptive immunity to SARS-CoV-2 and COVID-19;Sette;Cell.,2021

2. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity;Rydyznski Moderbacher;Cell.,2020

3. Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients;Tan;Cell Rep.,2021